Drug intelligence / Profile preview

8,12-dimethoxysanguinarine

Development stage
Preclinical
Modality
Small Molecules
01

Overview

8,12-dimethoxysanguinarine (SG-A) is a novel benzophenanthridine alkaloid derivative isolated from the Chinese medicinal herb *Eomecon chionantha*. It exhibits potent antineoplastic activity, specifically demonstrated in MCF-7 breast cancer cell lines with an IC50 value of 7.45 μM. Unlike many traditional chemotherapeutic agents that trigger apoptosis, SG-A has been shown to induce non-apoptotic cell death via the necroptosis pathway. This mechanism was confirmed through flow cytometry, Hoechst 33258 staining, and transmission electron microscopy (TEM) cell morphology analysis. Its ability to bypass apoptotic pathways suggests potential utility in treating both sensitive and treatment-resistant forms of breast cancer.

Other names
8,12-dimethoxy-sanguinarine
02

Targets

RIPK3MLKL (Mixed lineage kinase domain-like protein)RIPK1 (Receptor-interacting serine/threonine-protein kinase 1)

Beyond the preview

Go deeper on 8,12-dimethoxysanguinarine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 8,12-dimethoxysanguinarine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call